University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Leishmania Vaccine Study

Adults age 18 to 49 who are in overall good health are invited to participate in a study on the safety, tolerability, and effectiveness of a leishmaniasis vaccine.  There are 18 study visits (17 clinic visits and 1 phone call) required over a period of 18 months.  Compensation is provided.

To learn more, call 319-356-4848 or e-mail

Start Date
February 27, 2013
End Date
August 27, 2013
Gender Preference
Age Group
18 - 49 years
Principal Investigator
Patricia Winokur
Contact Info

Vaccine Research and Education Office 319-356-4848 or

Vaccine ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.